Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
Ahmad Ud Din, Maryam Mazhar, Muhammad Waseem, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110947-110947
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 97
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
Giuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 63
Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota
Olga V. Averina, Е. У. Полуэктова, М. В. Марсова, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1340-1340
Open Access | Times Cited: 82
Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features
Longxian Lv, Silan Gu, Huiyong Jiang, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 80
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
Monika Kvaková, Izabela Bertková, Jana Štofilová, et al.
Foods (2021) Vol. 10, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 64
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 60
The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients
Qiang Li, Fang Cheng, Qiling Xu, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107531-107531
Open Access | Times Cited: 56
The role of the microbiota in the management of intensive care patients
Piotr Szychowiak, Khanh Villageois-Tran, Juliette Patrier, et al.
Annals of Intensive Care (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review
Elham Zarenezhad, Hussein T. Abdulabbas, Ahmed Shayaa Kareem, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 6
Open Access | Times Cited: 22
Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 8
Autoimmunity and COVID-19 – The microbiotal connection
Nurit Katz‐Agranov, Gisele Zandman‐Goddard
Autoimmunity Reviews (2021) Vol. 20, Iss. 8, pp. 102865-102865
Open Access | Times Cited: 51
COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
Carlo Romano Settanni, Gianluca Ianiro, Francesca Romana Ponziani, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 43, pp. 7433-7445
Open Access | Times Cited: 49
A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease
Montaña Cámara, María de Cortes Sánchez‐Mata, Virginia Fernández-Ruíz, et al.
Foods (2021) Vol. 10, Iss. 5, pp. 1088-1088
Open Access | Times Cited: 47
The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20
Atieh Darbandi, Arezoo Asadi, Roya Ghanavati, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 91-104
Open Access | Times Cited: 46
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Indranil Chattopadhyay, Esaki M. Shankar
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 44
Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora
Khalid Saad Alharbi, Yogendra Singh, Waleed Hassan Almalki, et al.
Chemico-Biological Interactions (2022) Vol. 358, pp. 109898-109898
Open Access | Times Cited: 33
Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications
Maha Fahad Alenazy, Haya I. Aljohar, Ashwag R. Alruwaili, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 912-912
Open Access | Times Cited: 31
SARS‐CoV‐2 triggered oxidative stress and abnormal energy metabolism in gut microbiota
Tuoyu Zhou, Jingyuan Wu, Yufei Zeng, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 30
Exploiting the polyphenolic potential of honey in the prevention of chronic diseases
Wani Suhana Ayoub, Ritu, Insha Zahoor, et al.
Food Chemistry Advances (2023) Vol. 3, pp. 100373-100373
Open Access | Times Cited: 20
Relationship between Dietary Polyphenols and Gut Microbiota: New Clues to Improve Cognitive Disorders, Mood Disorders and Circadian Rhythms
Siyu Liu, Lu Cheng, Yanan Liu, et al.
Foods (2023) Vol. 12, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 18
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial
Mahsa Vaezi, Sahar Ravanshad, Mina Akbari Rad, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 16
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
Denise Battaglini, Chiara Robba, Andrea Fedele, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
The Microbiome Meets Nanotechnology: Opportunities and Challenges in Developing New Diagnostic Devices
Celia Fuentes‐Chust, Claudio Parolo, Giulio Rosati, et al.
Advanced Materials (2021) Vol. 33, Iss. 18
Open Access | Times Cited: 33
Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
Lei Xu, Chung S. Yang, Yanan Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Probioticsinfluencingresponse ofantibodies overtime inseniors afterCOVID-19vaccine (PIRATES-COV): a randomised controlled trial protocol
Jean‐Charles Pasquier, Mélanie Plourde, Sheela Ramanathan, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e088231-e088231
Open Access
Page 1 - Next Page

Scroll to top